Adage Capital Partners Gp, L.L.C. Abeona Therapeutics Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,072,985 shares of ABEO stock, worth $19.6 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,072,985
Previous 2,691,628
14.17%
Holding current value
$19.6 Million
Previous $12.8 Million
36.23%
% of portfolio
0.03%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding ABEO
# of Institutions
102Shares Held
31.6MCall Options Held
2.42MPut Options Held
212K-
Nantahala Capital Management, LLC New Canaan, CT4.37MShares$27.9 Million1.08% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.68MShares$17.1 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$16 Million0.0% of portfolio
-
Western Standard LLC Los Angeles, CA2.09MShares$13.3 Million6.61% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.84MShares$11.8 Million2.22% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $38M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...